# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Clearmind Medicine filed an international patent for a treatment that aims to enhance addiction treatment safety and efficacy.
Reported August 28: SciSparc Files For Sale Of Up To 21M Ordinary Shares Under $20M SEPA Agreement; Shares Priced At 97% Of Mar...
SciSparc would be entitled to receive consideration valued at $3 million in Polyrizon securities, as well as potential mileston...
SciSparc to conduct the trial at the Yale Child Study Center at the Yale School of Medicine in the USA, Hannover Medical School...